Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth and precocious puberty.

J L Chaussain1, C Couprie, F Lacaille

  • 1Hôpital Saint-Vincent-de-Paul, Paris, France.

Acta Paediatrica Scandinavica. Supplement
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Substitutive and dietetic approaches in childhood autistic disorder: interests and limits].

L'Encephale·2008
Same author

Linear and nonlinear optical response of aromatic amino acids: a time-dependent density functional investigation.

The journal of physical chemistry. A·2006
Same author

Development and first validation of the shared decision-making questionnaire (SDM-Q).

Patient education and counseling·2006
Same author

Assessment of diabetes screening by general practitioners in France: the EPIDIA Study.

Diabetic medicine : a journal of the British Diabetic Association·2006
Same author

Intermittent recombinant growth hormone treatment in short children born small for gestational age: four-year results of a randomized trial of two different treatment regimens.

Hormone research·2006
Same author

Water solvent effect on the first hyperpolarizability of p-nitrophenol and p-nitrophenylphosphate: a time-dependent density functional study.

The Journal of chemical physics·2006
Same journal

Gonadotrophin-releasing hormone analogues as therapeutic probes in human growth and development: evidence from children with central precocious puberty.

Acta paediatrica Scandinavica. Supplement·1991
Same journal

Growth hormone receptor deficiency (Laron syndrome): clinical and genetic characteristics.

Acta paediatrica Scandinavica. Supplement·1991
Same journal

The nature of nutritional deficiency in relation to growth failure and poverty.

Acta paediatrica Scandinavica. Supplement·1991
Same journal

Aspects of anthropometric evaluation of malnutrition in childhood.

Acta paediatrica Scandinavica. Supplement·1991
Same journal

Breast feeding and the older infant.

Acta paediatrica Scandinavica. Supplement·1991
Same journal

Can maternal dietary supplements help in preventing infant malnutrition?

Acta paediatrica Scandinavica. Supplement·1991
See all related articles

Gonadotropin-releasing hormone (GnRH) analogues effectively manage central precocious puberty by slowing growth and improving height potential. This treatment offers hope for better final height outcomes in affected children.

Area of Science:

  • Pediatric Endocrinology
  • Reproductive Medicine
  • Growth Disorders

Background:

  • Central precocious puberty involves early development of sexual characteristics and advanced bone age.
  • Previous treatments like medroxyprogesterone acetate and cyproterone acetate had limitations, including adrenal insufficiency and unclear effects on growth.
  • Gonadotropin-releasing hormone (GnRH) analogues represent a newer therapeutic option.

Purpose of the Study:

  • To evaluate the efficacy of a GnRH analogue in treating central precocious puberty.
  • To assess the impact on growth rate, bone maturation, and final height potential.
  • To determine the effectiveness in controlling gonadal secretions.

Main Methods:

  • A series of 21 patients (13 girls, 8 boys) with central precocious puberty were treated with a GnRH analogue.

Related Experiment Videos

  • Growth rate, bone age, height age, and gonadal secretions were monitored.
  • Preliminary data analysis was performed.

    • Main Results:

    • Treatment with the GnRH analogue led to a significant decrease in growth rate in both sexes.
    • A significant increase in the height age/bone age ratio was observed.
    • Effective control of gonadal secretions was achieved.

    Conclusions:

    • GnRH analogue therapy shows promise in managing central precocious puberty.
    • The treatment appears to improve the height age/bone age ratio, suggesting potential for improved final height.
    • Further preliminary data indicate positive outcomes for growth and puberty control.